|
000
| 01503nam 2200313za 4500 |
|---|
| 001 | 9.866237 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107162010 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 190115s2019 oncd o f000 0 eng d |
|---|
| 020 | |a9780660290560 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH82-31/2019E-PDF |
|---|
| 245 | 04|aThe market for prescription oral solid opioids, 2010 to 2017 |h[electronic resource] : |pCanada and the United States. |
|---|
| 260 | |aOttawa : |bPatented Medicine Prices Review Board, |cc2019. |
|---|
| 300 | |a43 p. : |bcol. charts |
|---|
| 500 | |aIssued also in French under title: Le marché des opioïdes d’ordonnance sous forme orale solide, de 2010 à 2017 : Canada et États-Unis. |
|---|
| 500 | |aCover title. |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 504 | |aIncludes bibliographic references. |
|---|
| 520 | |a"To provide an overview of the market for prescription opioids in Canada and the United States to inform discussions on the impact of the proposed regulatory changes"--Purpose of this analysis, p. 5. |
|---|
| 692 | 07|2gccst|aPrescription drugs |
|---|
| 693 | 4|aOpioids |
|---|
| 710 | 1 |aCanada. |bPatented Medicine Prices Review Board. |
|---|
| 775 | 08|tLe marché des opioïdes d’ordonnance sous forme orale solide, de 2010 à 2017 |w(CaOODSP)9.866239 |
|---|
| 856 | 40|qPDF|s894 KB|uhttps://publications.gc.ca/collections/collection_2019/cepmb-pmprb/H82-31-2019-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttp://www.pmprb-cepmb.gc.ca/view.asp?ccid=1417&lang=en |
|---|